These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

224 related articles for article (PubMed ID: 35421676)

  • 1. Damnacanthal isolated from morinda species inhibited ovarian cancer cell proliferation and migration through activating autophagy.
    Li R; Li H; Lan J; Yang D; Lin X; Xu H; Han B; Yang M; Su B; Liu F; Jiang W
    Phytomedicine; 2022 Jun; 100():154084. PubMed ID: 35421676
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Tanshinone I attenuates the malignant biological properties of ovarian cancer by inducing apoptosis and autophagy via the inactivation of PI3K/AKT/mTOR pathway.
    Zhou J; Jiang YY; Chen H; Wu YC; Zhang L
    Cell Prolif; 2020 Feb; 53(2):e12739. PubMed ID: 31820522
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Activation of PI3K/AKT/mTOR signaling axis by UBE2S inhibits autophagy leading to cisplatin resistance in ovarian cancer.
    Zhang M; Wang J; Guo Y; Yue H; Zhang L
    J Ovarian Res; 2023 Dec; 16(1):240. PubMed ID: 38115063
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Novel Platinum Nanoclusters Activate PI3K/AKT/mTOR Signaling Pathway-Mediated Autophagy for Cisplatin-Resistant Ovarian Cancer Therapy.
    Zhang M; Yue H; Huang X; Wang J; Li Z; Deng X
    ACS Appl Mater Interfaces; 2022 Nov; 14(43):48502-48514. PubMed ID: 36261925
    [TBL] [Abstract][Full Text] [Related]  

  • 5. SRT2183 impairs ovarian cancer by facilitating autophagy.
    Sun T; Hu Y; He W; Shang Y; Yang X; Gong L; Zhang X; Gong P; Yang G
    Aging (Albany NY); 2020 Nov; 12(23):24208-24218. PubMed ID: 33223507
    [TBL] [Abstract][Full Text] [Related]  

  • 6. RY-2f, an isoflavone analog, overcomes cisplatin resistance to inhibit ovarian tumorigenesis via targeting the PI3K/AKT/mTOR signaling pathway.
    Liu M; Qi Z; Liu B; Ren Y; Li H; Yang G; Zhang Q
    Oncotarget; 2015 Sep; 6(28):25281-94. PubMed ID: 26325371
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Daphnetin triggers ROS-induced cell death and induces cytoprotective autophagy by modulating the AMPK/Akt/mTOR pathway in ovarian cancer.
    Fan X; Xie M; Zhao F; Li J; Fan C; Zheng H; Wei Z; Ci X; Zhang S
    Phytomedicine; 2021 Feb; 82():153465. PubMed ID: 33486268
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Label-free-based quantitative proteomic analysis of the inhibition of cisplatin-resistant ovarian cancer cell proliferation by cucurbitacin B.
    Yin S; Mai Z; Liu C; Xu L; Xia C
    Phytomedicine; 2023 Mar; 111():154669. PubMed ID: 36681055
    [TBL] [Abstract][Full Text] [Related]  

  • 9. FAM83D inhibits autophagy and promotes proliferation and invasion of ovarian cancer cells via PI3K/AKT/mTOR pathway.
    Zhu H; Diao S; Lim V; Hu L; Hu J
    Acta Biochim Biophys Sin (Shanghai); 2019 May; 51(5):509-516. PubMed ID: 30939187
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Icariin enhances the chemosensitivity of cisplatin‑resistant ovarian cancer cells by suppressing autophagy via activation of the AKT/mTOR/ATG5 pathway.
    Jiang S; Chang H; Deng S; Fan D
    Int J Oncol; 2019 Jun; 54(6):1933-1942. PubMed ID: 31081049
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Damnacanthal and its nanoformulation exhibit anti-cancer activity via cyclin D1 down-regulation.
    Sukamporn P; Rojanapanthu P; Silva G; Zhang X; Gritsanapan W; Baek SJ
    Life Sci; 2016 May; 152():60-6. PubMed ID: 27018445
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Paeonol induces cytoprotective autophagy via blocking the Akt/mTOR pathway in ovarian cancer cells.
    Gao L; Wang Z; Lu D; Huang J; Liu J; Hong L
    Cell Death Dis; 2019 Aug; 10(8):609. PubMed ID: 31406198
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Autophagy inhibitor potentiates the antitumor efficacy of apatinib in uterine sarcoma by stimulating PI3K/Akt/mTOR pathway.
    Chen S; Yao L
    Cancer Chemother Pharmacol; 2021 Aug; 88(2):323-334. PubMed ID: 33978839
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Baicalein improves the chemoresistance of ovarian cancer through regulation of CirSLC7A6.
    Li S; Yi Z; Li M; Zhu Z
    J Ovarian Res; 2023 Nov; 16(1):212. PubMed ID: 37940982
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Autophagy-related gene PXN as a prognostic marker: Promotion of ovarian cancer progression by suppressing the p110β/Vps34/Beclin1 pathway.
    Wu Q; Cui Z; Jiang S; Xia H; Liu L; You Y; Sun Y
    Cell Biochem Funct; 2023 Jul; 41(5):599-608. PubMed ID: 37232085
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Poricoic acid A induces apoptosis and autophagy in ovarian cancer via modulating the mTOR/p70s6k signaling axis.
    Ma R; Zhang Z; Xu J; Liang X; Zhao Q
    Braz J Med Biol Res; 2021; 54(12):e11183. PubMed ID: 34669780
    [TBL] [Abstract][Full Text] [Related]  

  • 17. 4-Acetylantroquinonol B suppresses autophagic flux and improves cisplatin sensitivity in highly aggressive epithelial cancer through the PI3K/Akt/mTOR/p70S6K signaling pathway.
    Liu M; Bamodu OA; Huang WC; Zucha MA; Lin YK; Wu ATH; Huang CC; Lee WH; Yuan CC; Hsiao M; Deng L; Tzeng YM; Yeh CT
    Toxicol Appl Pharmacol; 2017 Jun; 325():48-60. PubMed ID: 28408137
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Fuzheng Jiedu Decoction Induces Apoptosis and Enhances Cisplatin Efficacy in Ovarian Cancer Cells
    Yang H; Li H; Lu S; Shan S; Guo Y
    Biomed Res Int; 2022; 2022():5739909. PubMed ID: 35281608
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Polypeptide LTX-315 reverses the cisplatin chemoresistance of ovarian cancer cells via regulating Beclin-1/PI3K/mTOR signaling pathway.
    Ma J; Liu L; Ling Y; Zheng J
    J Biochem Mol Toxicol; 2021 Sep; 35(9):e22853. PubMed ID: 34309113
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Knockdown of Hypoxia-Inducible Factor 1α (HIF-1α) Promotes Autophagy and Inhibits Phosphatidylinositol 3-Kinase (PI3K)/AKT/Mammalian Target of Rapamycin (mTOR) Signaling Pathway in Ovarian Cancer Cells.
    Huang J; Gao L; Li B; Liu C; Hong S; Min J; Hong L
    Med Sci Monit; 2019 Jun; 25():4250-4263. PubMed ID: 31175269
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.